Nexgel (NXGL) stock, explained like you're 5

Is Nexgel a small, medium or large cap company?

No. Nexgel is a micro cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Nexgel makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves NXGL stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• NEXGEL (NASDAQ:NXGL) Share Price | RNS News, Quotes, & Charts | NXGL | (Proactive financial news)
• NEXGEL Announces 1 for 20 Reverse Stock Split and Split Adjusted Trading on Nasdaq Capital Market (Quiver Quantitative)
• A medical technology company, NEXGEL, will update investors on operations Sept. 24 (Stock Titan)
• NEXGEL implements 1 for 20 reverse split as NEXGEL stock faces Nasdaq test (ad-hoc-news.de)
• NexGel shareholders approve share increase and reverse stock split proposals (Investing.com)

Key terms to know before you follow NXGL

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility